Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway

Experimental Cell Research

Volumn 318, Issue 5, 2012, Pages 558-569

  Karam, Manale ^a   Legay, Christine ^a   Auclair, Christian ^a   Ricort, Jean Marc ^a  

^a Ecole Normale Superieure de Cachan   (France)

Author keywords

Breast cancer; Proliferation; Protein kinase D1; Signal transduction; Tumorigenesis

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE D; PROTEIN KINASE D1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84857058592     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.01.001     Document Type: Article

References (47)

1. Abedi H., Rozengurt E., Zachary I. Rapid activation of the novel serine/threonine protein kinase, protein kinase D by phorbol esters, angiotensin II and PDGF-BB in vascular smooth muscle cells. FEBS Lett. 1998, 427:209-212.
2. Biswas M.H., Du C., Zhang C., Straubhaar J., Languino L.R., Balaji K.C. Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer. Cancer Res. 2010, 70:2095-2104.
3. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature 2001, 411:355-365.
4. Callans L.S., Naama H., Khandelwal M., Plotkin R., Jardines L. Raf-1 protein expression in human breast cancer cells. Ann. Surg. Oncol. 1995, 2:38-42.
5. Chen J., Deng F., Singh S.V., Wang Q.J. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. Cancer Res. 2008, 68:3844-3853.
6. Chiu T., Rozengurt E. PKD in intestinal epithelial cells: rapid activation by phorbol esters, LPA, and angiotensin through PKC. Am. J. Physiol. Cell Physiol. 2001, 280:C929-C942.
7. Clarke R., Dickson R.B., Brunner N. The process of malignant progression in human breast cancer. Ann. Oncol. 1990, 1:401-407.
8. Dequiedt F., Van Lint J., Lecomte E., Van Duppen V., Seufferlein T., Vandenheede J.R., Wattiez R., Kettmann R. Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J. Exp. Med. 2005, 201:793-804.
9. Eiseler T., Doppler H., Yan I.K., Goodison S., Storz P. Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res. 2009, 11:R13.
10. Eiseler T., Hausser A., De K.L., Van L.J., Pfizenmaier K. Protein kinase D controls actin polymerization and cell motility through phosphorylation of cortactin. J. Biol. Chem. 2010, 285:18672-18683.
11. Fields A.P., Gustafson W.C. Protein kinase C in disease: cancer. Methods Mol. Biol. 2003, 233:519-537.
12. Gee J.M., Robertson J.F., Ellis I.O., Nicholson R.I. Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. Int. J. Cancer 2001, 95:247-254.
13. Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H.J., Johannes F.J. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 1996, 392:77-80.
14. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
15. Hausser A., Storz P., Hubner S., Braendlin I., Martinez-Moya M., Link G., Johannes F.J. Protein kinase C mu selectively activates the mitogen-activated protein kinase (MAPK) p42 pathway. FEBS Lett. 2001, 492:39-44.
16. Hermanto U., Zong C.S., Wang L.H. Inhibition of mitogen-activated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen-activated protein kinase activation. Cell Growth Differ. 2000, 11:655-664.
17. Jaggi M., Rao P.S., Smith D.J., Hemstreet G.P., Balaji K.C. Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochem. Biophys. Res. Commun. 2003, 307:254-260.
18. Janes P.W., Daly R.J., deFazio A., Sutherland R.L. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 1994, 9:3601-3608.
19. Johannes F.J., Prestle J., Eis S., Oberhagemann P., Pfizenmaier K. PKCu is a novel, atypical member of the protein kinase C family. J. Biol. Chem. 1994, 269:6140-6148.
20. Lee Y.R., Park J., Yu H.N., Kim J.S., Youn H.J., Jung S.H. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Biochem. Biophys. Res. Commun. 2005, 336:1221-1226.
21. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
22. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marme D., Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 1993, 268:9194-9197.
23. Mueller H., Flury N., Eppenberger-Castori S., Kueng W., David F., Eppenberger U. Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients. Int. J. Cancer 2000, 89:384-388.
24. Paolucci L., Rozengurt E. Protein kinase D in small cell lung cancer cells: rapid activation through protein kinase C. Cancer Res. 1999, 59:572-577.
25. Parra M., Kasler H., McKinsey T.A., Olson E.N., Verdin E. Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J. Biol. Chem. 2005, 280:13762-13770.
26. Peterburs P., Heering J., Link G., Pfizenmaier K., Olayioye M.A., Hausser A. Protein kinase D regulates cell migration by direct phosphorylation of the cofilin phosphatase slingshot 1 like. Cancer Res. 2009, 69:5634-5638.
27. Prestle J., Pfizenmaier K., Brenner J., Johannes F.J. Protein kinase C mu is located at the Golgi compartment. J. Cell Biol. 1996, 134:1401-1410.
28. Reddy K.B., Glaros S. Inhibition of the MAP kinase activity suppresses estrogen-induced breast tumor growth both in vitro and in vivo. Int. J. Oncol. 2007, 30:971-975.
29. Rennecke J., Rehberger P.A., Furstenberger G., Johannes F.J., Stohr M., Marks F., Richter K.H. Protein-kinase-Cmu expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture. Int. J. Cancer 1999, 80:98-103.
30. Rozengurt E., Rey O., Waldron R.T. Protein kinase D signaling. J. Biol. Chem. 2005, 280:13205-13208.
31. Rozengurt E., Sinnett-Smith J., Van L.J., Valverde A.M. Protein kinase D (PKD): a novel target for diacylglycerol and phorbol esters. Mutat. Res. 1995, 333:153-160.
32. Sinnett-Smith J., Zhukova E., Hsieh N., Jiang X., Rozengurt E. Protein kinase D potentiates DNA synthesis induced by Gq-coupled receptors by increasing the duration of ERK signaling in swiss 3T3 cells. J. Biol. Chem. 2004, 279:16883-16893.
33. Sivaraman V.S., Wang H., Nuovo G.J., Malbon C.C. Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest. 1997, 99:1478-1483.
34. Storz P., Toker A. Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J. 2003, 22:109-120.
35. Torricelli C., Valacchi G., Maioli E. Novel PKCs activate ERK through PKD1 in MCF-7 cells. In Vitro Cell Dev. Biol. Anim. 2011, 47:73-81.
36. Trauzold A., Schmiedel S., Sipos B., Wermann H., Westphal S., Roder C., Klapper W., Arlt A., Lehnert L., Ungefroren H., Johannes F.J., Kalthoff H. PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. Oncogene 2003, 22:8939-8947.
37. Valverde A.M., Sinnett-Smith J., Van L.J., Rozengurt E. Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8572-8576.
38. Van Lint J.V., Sinnett-Smith J., Rozengurt E. Expression and characterization of PKD, a phorbol ester and diacylglycerol-stimulated serine protein kinase. J. Biol. Chem. 1995, 270:1455-1461.
39. Van L.J., Ni Y., Valius M., Merlevede W., Vandenheede J.R. Platelet-derived growth factor stimulates protein kinase D through the activation of phospholipase Cgamma and protein kinase C. J. Biol. Chem. 1998, 273:7038-7043.
40. Vega R.B., Harrison B.C., Meadows E., Roberts C.R., Papst P.J., Olson E.N., McKinsey T.A. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol. Cell. Biol. 2004, 24:8374-8385.
41. Wang Q.J. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol. Sci. 2006, 27:317-323.
42. Wang Y., Waldron R.T., Dhaka A., Patel A., Riley M.M., Rozengurt E., Colicelli J. The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. Mol. Cell. Biol. 2002, 22:916-926.
43. Wingo P.A., Tong T., Bolden S. Cancer statistics, 1995. CA Cancer J. Clin. 1995, 45:8-30.
44. Wong C., Jin Z.G. Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J. Biol. Chem. 2005, 280:33262-33269.
45. Woods A.J., White D.P., Caswell P.T., Norman J.C. PKD1/PKCmu promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. EMBO J. 2004, 23:2531-2543.
46. Zhukova E., Sinnett-Smith J., Rozengurt E. Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells. J. Biol. Chem. 2001, 276:40298-40305.
47. Zugaza J.L., Waldron R.T., Sinnett-Smith J., Rozengurt E. Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway. J. Biol. Chem. 1997, 272:23952-23960.